House com­mit­tee ad­vances bills aimed at or­phan ex­clu­siv­i­ty, gener­ic la­bel­ing and con­tin­u­ous man­u­fac­tur­ing

The House En­er­gy and Com­merce Com­mit­tee on Wednes­day ad­vanced 17 health-re­lat­ed bills for con­sid­er­a­tion by the House, sev­er­al of which have im­pli­ca­tions for the FDA’ …

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER